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Streptococcus suis (S.suis) is an important zoonotic pathogen that causes severe
diseases in humans and pigs. Biofilms of S. suis can induce persistent infections that
are difficult to treat. In this study, the effect of tylosin on biofilm formation of S. suis
was investigated. 1/2 minimal inhibitory concentration (MIC) and 1/4 MIC of tylosin
were shown to inhibit S. suis biofilm formation in vitro. By using the iTRAQ strategy,
we compared the protein expression profiles of S. suis grown with sub-MIC tylosin
treatment and with no treatment. A total of 1501 proteins were identified by iTRAQ.
Ninety-six differentially expressed proteins were identified (Ratio > ±1.5, p < 0.05).
Several metabolism proteins (such as phosphoglycerate kinase) and surface proteins
(such as ABC transporter proteins) were found to be involved in biofilm formation. Our
results indicated that S. suis metabolic regulation, cell surface proteins, and virulence
proteins appear to be of importance in biofilm growth with sub-MIC tylosin treatment.
Thus, our data revealed the rough regulation of biofilm formation that may provide a
foundation for future research into mechanisms and targets.
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INTRODUCTION
Streptococcus suis (S. suis) is an important zoonotic pathogen that causes a wide range of diseases in
pigs, including meningitis, septicaemia, pneumonia, endocarditis, and arthritis (Gottschalk et al.,
2010). In addition, this pathogen is an emerging zoonotic agent and an important public health
issue in East and Southeast Asia (Sriskandan and Slater, 2006; Gottschalk et al., 2007). During a
single outbreak in China in 2005, more than 200 human cases of S. suis were reported, with a death
total of 39 (Yang et al., 2006). Current studies show that S. suis can cause persistent infections by
forming biofilms in vivo (Wang et al., 2011).
Biofilms are assemblages of microorganisms characterized by cells that are irreversibly attached
to a substratum and embedded in a matrix of self-produced extracellular polymeric substances
such as exopolysaccharides (EPS), proteins, nucleic acids and other substances; this type of sessile
community-based existence is a critical characteristic for bacterial persistence (Davey and O’Toole,
2000). The physical and biological properties of the biofilm, such as slow growth and mechanical
barrier, have a substantial role in the development of increased antimicrobial tolerance. Because the
bacteria in chronic infections are aggregated and are in close proximity, genes coding for resistance
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to antimicrobials can be passed horizontally from one bacterium
to the another (Bjarnsholt et al., 2013). The bacteria in biofilms
could be 1000-times more difficult to kill by antibiotics than
the same organism growing planktonically (Gilbert et al., 1997).
Therefore, the control of biofilms is understood to be crucial.
Apart from surgical intervention (when applicable),
antibiotics are the main option for the treatment of biofilm
infections (Bjarnsholt et al., 2013). Previous studies showed that
macrolides successfully inhibited Staphylococcus aureus biofilm
formation and reduced its virulence when used at sub-inhibitory
concentrations (Fujimura et al., 2008). In addition, a sub-
minimal inhibitory concentration of erythromycin can inhibit S.
suis biofilm formation (Zhao et al., 2015). Tylosin, a macrolide
antibiotic produced by Streptomyces fradiae, is widely used as a
veterinary medicine. However, there is still not much effective
research of sub-MIC tylosin inhibiting biofilm formation of S.
suis in vitro.
At present, most of the available information regarding
biofilm formation by drug intervention is based on
transcriptomic analyses. However, a limitation of transcriptomic
analysis for identifying biofilm-regulated gene network raised
concerns among investigators. The method of proteomics is
thought to be an essential complement to transcriptomic analysis
for discovering key regulators of biofilm (Sauer, 2003). Different
immunogenic components of planktonically grown S. suis
proteins such as secreted or cell wall-associated proteins had
been studied by using immunoproteomic assays (Zhang and Lu,
2007a,b; Geng et al., 2008; Zhang et al., 2008). Additionally, our
lab found that quorum-sensing played a crucial role leading to
biofilm formation through quantitative proteomic analysis of S.
suis biofilm inhibited by sub-MIC erythromycin treatment in
vitro (Zhao et al., 2015). However, there are no reports regarding
the proteomic analysis of sub-MIC tylosin inhibiting biofilm
formation of S. suis in vitro.
We identified several proteins in sub-MIC tylosin inhibiting
biofilm formation of S. suis by using iTRAQ technology in
this study. The findings from the present study may provide a
theoretical foundation for therapy of S. suis biofilm infection and
provide references for finding new potential therapeutic targets.
MATERIALS AND METHODS
Growth of S. suis Planktonic Cells
S. suis (ATCC 700794) was grown in Todd-Hewitt yeast Broth
(THB; Summus Ltd., Harbin, Heilongjiang, China) for 16–18 h at
37◦Cwith constant shaking for biofilm assays (Wang et al., 2011).
Observation by Scanning Electron
Microscopy (SEM)
Mid-exponential growth phase cultures of S. suis ATCC 700794
were adjusted to an optical density of 0.1 at 600 nm (OD600).
Then, 2mL cultures were transferred to the wells of a 6-well
microplate containing an 11× 11mm sterilized rough glass slide
(Mosutech Co., Ltd., Shanghai, China) on the bottom. After
culturing for 72 h at 37◦C without shaking, the glass slide was
removed with tweezers, and the biofilms on the rough glass slide
were washed with sterile PBS. The remaining biofilms were fixed
with fixative solution [4% (w/v) paraformaldehyde, 2.5% (w/v)
glutaraldehyde, 2mM CaCl2 in 0.2M cacodylate buffer, pH 7.2]
for 6 h and washed three times with 0.1M PBS 10min each,
then fixed in 2% osmium tetroxide containing 2mM potassium
ferrocyanide and 6% (w/v) sucrose in cacodylate buffer. The
samples were dried, gold sputtered with an ion sputtering
instrument (current 15mA, 2min) and observed using SEM (FEI
Quanta, Netherland).
Effect of Tylosin on Biofilm Formation
Determined by the TCP Assay
Mid-exponential growth phase cultures of S. suiswere adjusted to
0.2 of OD600. Then, 100µL of cultures were added to each wells
of a 96-well microplate with equal volume of tylosin solution
with the final concentrations of 1/2 MIC (0.25µg/mL), 1/4
MIC (0.125µg/mL), 1/8 MIC (0.0625µg/mL), and 1/16 MIC
(0.03125µg/mL), respectively. In addition, a negative control
(with THB alone) and a positive control (with bacteria alone)
were also included. After incubation at 37◦C for 72 h without
shaking, the medium was removed by aspiration and the wells
were washed three times with sterile physiological saline. The
remaining attached bacteria were fixed with 200µL of 99%
methanol (Guoyao Ltd., China) per well, and the plates were
emptied after 15min and left to dry. Then, the plates were stained
for 5min with 200µL of 2% crystal violet (Guoyao Ltd., China)
per well. The excess stain was rinsed off by placing the plate under
running tap water. After the plates were air dried, the dye bound
to the adherent cells was resolubilized with 200µL of 33% (v/v)
glacial acetic acid (Guoyao Ltd., China) per well. The amount
of released stain was quantified by measuring the absorbance
at 570 nm with a microplate reader (DG5033A, Huadong Ltd.,
Nanjing, Jiangsu, China). The reported values are the means
of three measurements. The experiments were performed in
triplicate.
Colony Forming Unit (CFU) Enumeration
Overnight cultures of S. suis were adjusted to an OD 600 of 0.2.
Then, the bacteria were inoculated into 96-well microtiter plate
wells containing 200µL of THB alone (untreated wells) or adding
the tylosin solution with the final concentrations of 1/4 MIC
(0.125µ g/mL). In addition, a negative control (with THB alone)
and a positive control (with bacteria alone) were also included.
After incubation at 37◦C for 72 h without shaking, the medium
was removed by aspiration, and the wells were washed three
times with sterile physiological saline. Biofilm cells were removed
from wells by sonication for 5min in 200µL of THB. The cell
suspensions (n= 3) underwent 10-fold dilutions in THB, and 100
µL of each dilution was spot plated onto THB soft-agar plates and
incubated at 37◦C for 24 h. All the experiments were performed
in triplicate.
Preparation of Protein Extracts
For biofilm cultures, S. suis was grown in THB in 100mm
polystyrene petri dishes at 37◦C for 24 h. Then, the supernatant
was removed and the dishes were washed twice with Tris-
HCl buffer (50mM, pH 7.5). The biofilms were detached
by scraping. After being sonicated for 5min (Bransonic 220;
Branson Consolidated Ultrasonic Pvt. Ltd., Australia), the cells
were centrifuged at 12,000×g for 10min at 4◦C. Then, the cell
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pellets were washed twice with Tris-HCl buffer (Wang et al.,
2012).
Protein Digestion and iTRAQ Labeling
Protein digestion was performed according to the reported FASP
procedure (Wisniewski et al., 2009). In brief, 200µg of proteins
at two different conditions (1/4 MIC of tylosin treated cells
and nontreated cells) were added into 30µL STD buffer (4%
SDS, 100mM DTT, 150mM Tris-HCl pH 8.0) and ultrafiltered
(Microcon units, 30 kD) with UA buffer (8M Urea, 150mM
Tris-HCl pH 8.0). To block reduced cysteine residues, 100µL
0.05M iodoacetamide was added into UA buffer and incubated
for 20min in the dark. The filters were washed three times with
100µL UA buffer and twice with 100µL DS buffer (50mM
triethylammoniumbicarbonate at pH 8.5). Finally, the proteins
were digested with 2µg trypsin (Promega) in 40µL DS buffer
at 37◦C for 16–18 h. Then, the resulting peptides were collected
as a filtrate. The peptide content was estimated by UV light
spectral density at 280 nm using an extinctions coefficient of 1.1
of 0.1% (g/l) solution calculated on the basis of the frequency of
tryptophan and tyrosine in vertebrate proteins.
For the iTRAQ labeling, the peptides were labeled with the 8-
plex iTRAQ reagent by following the manufacturer’s instructions
(Applied Biosystems). Each iTRAQ reagent was dissolved in
70µL of ethanol and added to the respective peptide mixture.
The peptides from the S. suis biofilms treated by tylosin were
labeled with 115 isobaric reagent, and the peptides from the
nontreated S. suis biofilms were labeled with 116 isobaric reagent.
Then, the samples were multiplexed and vacuum dried. Three
independent biological experiments were performed.
Peptide Fractionation with Strong Cation
Exchange (SCX) Chromatography
SCX chromatography using the AKTA Purifier system (GE
Healthcare) was used to fractionate the iTRAQ labeled peptides.
After being reconstituted and acidified with 2mL buffer A
(10mM KH2PO4 in 25% of ACN, pH 2.7), the peptides were
loaded onto a PolySULFOETHYL 4.6 × 100mm column (5µm,
200 Å, PolyLC Inc., Maryland, U.S.A.). Then, the peptides were
eluted at 1ml/min with a gradient of 0–10% buffer B (500mM
KCl, 10mM KH2PO4 in 25% of ACN, pH 2.7) for 2min, 10–
20% buffer B for 25min, 20–45% buffer B for 5min, and 50–100%
buffer B for 5min. The elution was monitored by absorbance at
214 nm, and the fractions were collected after every 1min. The
collected fractions (∼30 fractions) were combined into 10 pools
and desalted on C18 Cartridges [EmporeTM SPE Cartridges C18
(standard density), bed I.D. 7mm, volume 3ml, Sigma]. Each
pooled fraction was concentrated by vacuum centrifugation and
reconstituted in 40µl of 0.1% (v/v) trifluoroacetic acid and stored
at−80◦C for LC-MS/MS analysis.
Liquid Chromatography (LC) Electrospray
Ionization (ESI) Tandem Ms (MS/MS)
Analysis by Q Exactive
Experiments were performed on a Q Exactive mass spectrometer
that was coupled to Easy nLC (Thermo Fisher Scientific). A
sample (10µL) of each fraction was injected for the nano LC-
MS/MS analysis. The peptide mixture (5µg) was loaded onto
a C18-reversed phase column (Thermo Scientific Easy Column,
10 cm long, 75µm inner diameter, 3µm resin) in buffer A
(0.1% formic acid) and separated with a linear gradient of
buffer B (80% acetonitrile and 0.1% formic acid) at 250 nl/min
controlled by IntelliFlow technology for 140min. MS data were
acquired using a data-dependent top10 method dynamically
choosing the most abundant precursor ions from the survey scan
(300–1800m/z) for HCD fragmentation. Determination of the
target value was based on predictive Automatic Gain Control
(pAGC). The dynamic exclusion duration was 60 s. Survey scans
were acquired at a resolution of 70,000 at m/z 200, and the
resolution for HCD spectra was set to 17,500 at m/z 200. The
normalized collision energy was 30 eV, and the underfill ratio,
which specifies the minimum percentage of the target value
likely to be reached at maximum fill time, was defined as 0.1%.
The instrument was run with the peptide recognition mode
enabled.
Sequence Database Searching and Data
Analysis
The MS/MS spectra were searched using the MASCOT engine
(Matrix Science, London, UK; version 2.2) in the Proteome
Discoverer 1.3 (Thermo Electron, San Jose, USA.) against the
Uniprot S. suis fasta database (38,369 sequences, downloaded
March 4th, 2013) and the decoy database. False discovery rates
(FDR) were calculated by running all spectra against a decoy
database using the MASCOT software. To identify proteins, the
following options were used: Peptide mass tolerance = 20 ppm,
MS/MS tolerance = 0.1 Da, Enzyme = Trypsin, Missed
cleavage= 2, Fixed modification: Carbamidomethyl (C), iTRAQ
8plex (K), iTRAQ 8plex (N-term), Variable modification:
Oxidation (M). The quantification was performed based on the
peak intensities of the reporter ions in the MS/MS spectra.
The ratio of label 115 and 116 represents the expression
of proteins with the protein identification confidence of a
1% FDR (Unwin et al., 2010). The proteins were considered
over expressed when the iTRAQ ratio was above 1.5 and
under expressed when the iTRAQ ratio was lower than 0.67.
The Proteome Discoverer tool was used to categorize the
proteins detected by Gene Ontology (GO) annotation according
to the cellular component, biological process and molecular
function.
RESULTS
Effect of Tylosin against Biofilm Formation
In vitro by the TCP Assay
We evaluated the action of tylosin on biofilm growth in vitro. The
MIC against S. suis was 0.5µg·mL−1. Tylosin at 1/2 MIC and
1/4 MIC caused a significantly higher reduction in the biofilm-
forming ability of S. suis compared with positive control (p <
0.05). However, there was no pronounced effect for 1/16 MIC
and 1/8 MIC of tylosin on biofilm formation of S. suis (p > 0.05;
Figure 1).
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Direct Observation of Biofilm Formation In
vitro by Sem
SEM analysis was performed to observe the 1/4 MIC of tylosin
treated cells and nontreated cells biofilm formation by S. suis
under same growth conditions. As shown in Figure 2A, the
surface of the glass slide is almost entirely covered by the
aggregates and microcolonies of S. suis when growth was carried
out in the culture medium without tylosin. However, when the
culture medium was added to 1/4 MIC of tylosin, the biofilms
were characterized by the presence of small clusters of cells
interspersed amongst individual cells (Figure 2B). This result
showed that the biofilm formation of S. suis was inhibited by the
tylosin of 1/4 MIC in vitro.
Colony Forming Unit (CFU) Enumeration
To better assess action of tylosin on biofilm quantitatively, the
CFUs of S. suis were counted. The viability of S. suis treated with
1/4 MIC of tylosin was different from the viability of untreated
S. suis. The number of CFUs/mL in treated biofilms (5.3 log10
CFUs/mL) was significantly fewer than in nontreated biofilms
(6.5 log10 CFUs/mL; p < 0.05). The number of CFUs/mL in
treated biofilms (5.3 log10 CFUs/mL) was significantly fewer than
in nontreated biofilms (6.5 log10 CFUs/mL; p < 0.05) (Figure 3).
The findings demonstrated that 1/4 MIC of tylosin remained
effective in decreasing the viability of S. suis.
FIGURE 1 | Effect of tylosin at different concentrations on S. suis ATCC
700794 biofilm formation. The data are expressed as the means ± standard
deviations. Significant decrease (*p < 0.05) compared with control biofilm
formation of S. suis in vitro.
FIGURE 2 | (A) Biofilm formation of S. suis without tylosin. (B) Biofilm
formation of S. suis with 1/4 MIC tylosin treatment.
Sub-MIC Tylosin Inhibits Biofilm Formation
and Differentially Expressed Proteins by
iTRAQ
A total of 1501 proteins were identified by iTRAQ. Detailed
information is shown in the Supplementary File. A ratio
of proteins with >1.5 or <0.67 (p < 0.05) was considered
to be differentially expressed. Based on this criterion, 96
differentially expressed proteins were identified in 1/4 MIC
tylosin treated cells and nontreated cells. Detailed information
could is shown Table 1. These proteins were detected by GO
annotation. Thirty-five proteins were deleted from the database.
The remaining 61 proteins were classified into biological
process, molecular function and cellular component (Figure 4).
The results regarding the biological process were as follows:
single-organism process (8, 13%), response to stimulus (4,
7%), localization (4, 7%), biological adhesion (1, 2%), cellular
component organization or biogenesis (6, 10%), cellular process
(25, 41%), biological regulation (3, 5%), metabolic process (30,
49%). The results regarding molecular function were as follows:
binding (29, 48%), nucleic acid binding transcription factor
activity (1, 2%), transporter activity (3, 5%), structural molecule
activity (5, 8%), catalytic activity (25, 41%). The results regarding
cellular component were as follows: organelle (6, 10%), virion (1,
2%), cell (13, 21%), extracellular region (1, 2%), membrane (6,
10%), macromolecular complex (8, 13%).
DISCUSSION
ATCP assay is based on the ability of bacteria to form biofilms on
the bottom of tissue culture plates and is mainly used to identify
the formation of bacterial biofilms (Mathur et al., 2006; Okajima
et al., 2006; Presterl et al., 2007). Bacteria are grown in cell culture
plates, and the quantity of a biofilm is detected by staining the
wells with crystal violet according to the correlation between OD
values and biofilm formation (Mathur et al., 2006).
To further confirm S. suis biofilm formation, the structure of
the S. suis biofilmwas identified by scanning electronmicroscopy
FIGURE 3 | Effect of 1/4 MIC of tylosin on S. suis ATCC 700794 biofilm
formation by colony forming unit (CFU) enumeration. The data are
expressed as the means ± standard deviations. Significant decrease (*p <
0.05) compared with control biofilm formation of S. suis in vitro.
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TABLE 1 | List of differentially expressed proteins in tylosin treated cells.
Accession Description Fold changea
G7SDH9 Putative uncharacterized protein 0.555777
A4W1G9 Phosphotransferase system cellobiose-specific
component IIC
0.521547
G7SA24 Cold-shock DNA-binding domain protein 0.394546
F4EDP5 Putative uncharacterized protein 0.568016
R4NL31 MF3-like protein 0.63094
E9NQ29 CPS16V 0.452748
G5KZ73 NADH:flavin oxidoreductase/NADH oxidase family
protein
0.459622
G7S4C2 Major membrane immunogen,
membrane-anchored lipoprotein
0.643938
A8CUL3 Integrase 0.46773
G7SM99 Type I site-specific restriction-modification system,
R (Restriction) subunit and related helicase
0.506277
G7SLJ0 Putative competence-damage inducible protein 0.564703
A4W1W3 F0F1-type ATP synthase, subunit a 0.586873
G7RZW0 Sugar ABC transporter permease 1.508325
G7S2T8 Alcohol dehydrogenase 0.610195
G7SDG9 Laminin binding protein 1.524593
R4NLJ6 Oligopeptide ABC transporter, periplasmic
oligopeptide-binding protein OppA
0.644177
G7S371 Fructose-bisphosphate aldolase 0.623705
M1UGE2 Uncharacterized protein 0.647168
A4VZM2 Cell cycle protein GpsB 0.631018
A4W2D2 Cation transport ATPase 1.676356
G5L1V6 50S ribosomal protein L9 0.6638821
G7SEP2 Putative uncharacterized protein 1.502566
A4VVZ3 tRNA dimethylallyltransferase 1.510883
G7S5B8 3-isopropylmalate dehydrogenase 1.513117
G7SA68 UDP-N-acetylmuramate–alanine ligase 0.656503
G5L098 Transcriptional regulator Spx 1.514636
E8UKC3 Uncharacterized protein 1.507837
G7SFU4 Putative uncharacterized protein 1.543591
A4VV99 DNA repair protein 1.545594
A4W2Z7 FMN-dependent NADH-azoreductase 1.527496
F4EC05 Putative uncharacterized protein 1.57743
C6GNL8 30S ribosomal protein S21 1.545471
K7ZNG8 DNA recombination/repair protein (Fragment) 1.558023
G7S3K5 ABC-type cobalt transport system, ATPase
component
1.583854
G7SM56 Ribosomal RNA small subunit methyltransferase H 1.594936
A2VC24 Muramidase-released protein 1.579304
A4W3C1 Putative phosphotyrosine protein phosphatase 1.60975
G7S4U0 Putative uncharacterized protein 1.596783
G7SP92 Putative uncharacterized protein 1.658448
G7S7E3 Helicase 1.516925
M1VK55 Glycosyltransferase 1.662795
G7S3P9 Putative uncharacterized protein 1.673475
A4W106 Signal transduction histidine kinase 1.62492
B0M0G7 Phosphomethylpyrimidine kinase (Fragment) 1.633436
A5JSJ7 Putative uncharacterized protein 1.681661
G5L226 Type III restriction-modification system, restriction
endonuclease subunit
1.697991
(Continued)
TABLE 1 | Continued.
Accession Description Fold changea
G7S7K4 Putative uncharacterized protein 1.645719
B9WY95 Peptidase M20 1.647536
G7S4T2 Branched-chain alpha-keto acid dehydrogenase
subunit E2
1.673032
G5KX48 ABC-type uncharacterized transport system,
permease component
1.705109
G7S178 Putative uncharacterized protein 1.774886
M1VDL7 ABC transporter permease protein 1.942183
G7S6Z3 Putative uncharacterized protein 1.956584
J7KIA5 Abortive infection bacteriophage resistance
related protein
1.999106
G7SJZ7 Primosomal protein N’ 1.720079
G7SHW7 Putative uncharacterized protein 2.001559
Q9EZW2 Elongation factor Tu (Fragment) 1.739971
A4VVJ5 Uncharacterized protein 2.141695
M1VJZ8 Zeta toxin 1.74309
G5L2V0 NADPH:quinone reductase and related
Zn-dependent oxidoreductase
1.79706
R4NU43 Aromatic amino acid aminotransferase gamma
@ N-acetyl-L,L-diaminopimelate
aminotransferase
2.144605
A4W296 Uncharacterized protein 1.837367
G7SKQ0 CHAP domain containing protein 2.179882
B9WVD6 Putative uncharacterized protein (Fragment) 2.226792
G5L2N5 L-fucose isomerase 1.859887
B9WTA1 Putative uncharacterized protein 2.290848
B9WXU6 ABC transporter related protein 1.873566
G8DU82 Transposase 2.376768
G7S242 Putative ABC transporter 1.883471
A4VZ91 50S ribosomal protein L32 1.915877
G7SDX6 50S ribosomal protein L7/L12 1.918196
G5KZ86 Phosphatidylserine/phosphatidylglycerophosphate/
cardiolipin synthase-like protein
1.965488
G7SIQ5 Putative uncharacterized protein 2.451703
G7S7J2 Putative uncharacterized protein 2.481527
G7SPA1 Putative scaffolding protein 2.584249
G7S7A9 FAD-dependent pyridine nucleotide-disulfide
oxidoreductase
1.970356
G7S8Q2 Peptidase M22 glycoprotease 1.978772
M1TIM7 Methylated DNA-protein cysteine
methyltransferase
2.161583
G7SBK2 Elongation factor Ts 2.266517
M1VE47 Fic/DOC family protein 2.606274
M1UFP9 Thiamine-phosphate synthase 2.298028
G7S535 Fructose-6-phosphate aldolase 2.553516
G5L351 NsuB 2.694988
B9WUV5 Transcriptional regulator, DeoR family 2.65073
R4NW55 Plasmid replication protein Rep and AAA-class
ATPase domain protein
2.779765
G7RZ18 Sortase-like protein 2.791504
S6B433 RecN protein (Fragment) 3.007243
G5KZR3 Glutathione S-transferase 3.262393
R4NLK5 SSU ribosomal protein S1p 3.46851
R4NWB6 Uncharacterized protein 8.306942
(Continued)
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TABLE 1 | Continued.
Accession Description Fold changea
G5L259 NADP-dependent glyceraldehyde-3-phosphate
dehydrogenase, putative
2.781098
D5AFN4 Xaa-Pro dipeptidyl-peptidase 3.095053
G7SMG3 Elongation factor G 3.667679
G7SD52 ABC superfamily ATP binding cassette
transporter, membrane protein
3.201581
G5L1N9 Nucleoid DNA-binding protein 3.796473
G7S8P5 Phosphoglycerate kinase 11.34908
Fold changea, the ratio of different expression level between Sub-MIC tylosin treated cells
and nontreated cells.
(SEM). The biofilm examination relied heavily on SEM. Because
of its high magnification, the biofilm microstructure is observed
clearly. These findings further confirm that S. suis can form
biofilms in vitro. Although these procedures have their
advantages, the TCP procedure lacks specificity and sensitivity
because crystal violet stains all of the components of the biofilm
and could potentially stain non-biofilm material. More specific
and sensitive techniques can be performed to assess each of
the individual components. This method is good for screening
purposes.
Tylosin is a frequently used drug for the treatment of S.
suis infection. Upon treatment with this antimicrobial agent, S.
suis is inevitably exposed to a sub-inhibitory level of the agent.
Therefore, we studied its effect in sub-inhibitory concentrations
on S. suis biofilm formation. Tylosin can inhibit S. suis biofilm
formation at sub-inhibitory concentrations in a dose-dependent
manner. In addition, the inhibition of biofilm formation
varied among the antimicrobial agents. Numerous reports have
showed biofilm formation in the presence of sub-inhibitory
concentrations of antimicrobial agents (Dunne, 1990; Carsenti-
Etesse et al., 1993; Rupp and Hamer, 1998; Rachid et al., 2000;
Yang et al., 2015). Our results are in agreement with these
previous findings. Our results showed a better activity of tylosin
against S. suis biofilm formation. However, further studies should
be conducted to confirm and clarify the relationship between
the relative adherence-inhibiting properties of tylosin and their
mechanisms. These results may provide information regarding
the clinical use of antimicrobial agents against biofilm-forming
bacteria.
Our data identified proteins related to biofilm growth that
have previously been uncharacterized. iTRAQ analyses showed
that the regulation of metabolism plays a key role during S. suis
biofilm growth. First, the iTRAQ quantitative data revealed that
carbohydrate metabolism may be particularly important during
S. suis biofilm growth. It was reported that fructose bisphosphate
aldolase and glyceraldehyde-3-phosphate dehydrogenase were
significantly decreased in Streptococcus pneumoniae biofilms
(Allan et al., 2014). In our study, there was a >two-fold
increase of glyceraldehyde-3-phosphate dehydrogenase in the
tylosin inhibiting biofilm formation. In addition, the levels
of fructose bisphosphate aldolase (fold change: 0.62) were
down-regulated. It was reported that phosphoglycerate kinase
was up-regulated in S. suis biofilms compared with planktonic
cells by comparative proteomic analysis (Wang et al., 2012).
Similarly, biofilms of Pseudomonas aeruginosa (Sauer et al.,
2002) and Staphylococcus xylosus (Planchon et al., 2009)
exhibit up-regulated phosphoglycerate kinase. There was a
>11-fold increase in the level of phosphoglycerate kinase in
the tylosin inhibiting biofilm formation. Phosphoglycerate
kinase is a glycolytic enzyme that functions in the conversion
of glyceraldehyde 3-phosphate into 1, 3-diphosphoglycerate.
Glycolysis may play a pivotal role during S. suis biofilm growth.
Furthermore, histidine metabolism may play an important
role in biofilm formation. Histidine kinase (fold change: 1.62)
was up-regulated in the tylosin-inhibited biofilm formation.
Compared with other amino acids, L-His had the strongest
effect on biofilm induction (Cabral et al., 2011). Histidine
metabolism is also found to be involved in biofilm formation
and is confirmed by gene disruption (Cabral et al., 2011).
Histidine kinase is an important signaling molecule in biofilm
formation in gram-positive and negative bacteria (McLoon et al.,
2011; Shemesh and Chai, 2013; Yang et al., 2014; Grau et al.,
2015). In addition, several ABC transporter system proteins
were significantly up-regulated in the tylosin inhibiting biofilm
formation. This finding is consistent with the previous results
of our laboratory showing that sub-MIC erythromycin inhibits
S. suis biofilm formation (Zhao et al., 2015). The carbohydrate
substrate selection and fermentation determine ABC transporter
proteins were significantly up-regulated in tylosin-treated cells,
suggesting that S. suis had the capability of metabolizing a wide
range of carbohydrates during biofilm development (Hardy
et al., 2001; Marion et al., 2011; Bidossi et al., 2012; Haertel et al.,
2012). Moreover, ABC transporters are important because they
regulate respiration and biofilm formation, which in turn affect
the rate of electricity production and bioremediation (Selvaraj
et al., 2014). Furthermore, in the mutants of a pneumococcal
biofilm screen, ABC transporters were shown to be defective in
colonization (Munoz-Elias et al., 2008).
Cell surface proteins play a crucial role in biofilms. Within
the biofilm, bacterial cells are embedded in a self-produced
extracellular matrix. This matrix protects bacteria against a
number of environmental insults. However, the matrix also
confines bacterial access to fresh nutrients. Thus, the verified
increase in the expression of transmembrane channels appears
to be an essential requirement for the entrance of important
nutrient-containing fluid (Costerton et al., 1994). In addition
to acting, as channels, porins may act as potential targets
for adhesion to other cells and may mediate cell attachment
through binding to the proteins released for biofilm formation
(Dallo et al., 2010). The outer membrane proteins may mediate
cell attachment through binding to the released proteins for
biofilm formation. Membrane proteins such as OmpA mediate
cell adhesion in Acinetobacter baumannii (Dallo et al., 2010).
The key developmental stages of biofilm development have
been reported to be adhesion to surfaces, aggregation of micro
colonies, and further expansion of the microbial community. The
putative involvement of many genes encoding large cell surface
proteins is adhesion to the epithelium and biofilm formation
(Pridmore et al., 2004; Walter et al., 2005; Frese et al., 2011).
Pham (Pham et al., 2010) found increased expression of outer
membrane proteins in the Tannerella forsythia biofilm cells
by using quantitative non-gel-based proteomic techniques. In
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FIGURE 4 | Annotation of differentially regulated protein (ratio >1.5 or <0.67) functions by Gene Ontology (GO).
our study, the expression of membrane-anchored lipoprotein,
phosphoglycerate kinase, sugar ABC transporter permease,
ABC superfamily ATP binding cassette transporter membrane
protein and L-fucose isomerase changed; these proteins belong
to membrane proteins and cell-surface proteins and might
be involved in some molecular functions including catalytic
activity, motor activity, nucleotide binding, protein binding and
transporter activity. For example, phosphoglycerate kinase is a
S. suis surface protein that promotes cell adhesion and plays a
key role in bacterial infection and invasion (Brassard et al., 2004;
Wang and Lu, 2007).We predicted that these membrane proteins
might affect the bacterial cell-cell interaction. Thus, membrane
proteins might play a significant role in biofilm formation.
S. suis virulence proteins related to infection, persistence and
competitive fitness were mostly down regulated when sub-MIC
tylosin was used to inhibit biofilm formation. There was a >1.5-
fold decrease in the level of NADH oxidase. NADH oxidase
regulates competence, virulence, and pneumococcal persistence
by its actions as an oxygen sensor, in detoxifying oxygen, and
in increasing the efficiency of glucose breakdown (Auzat et al.,
1999) and plays an important role in pneumococcal infection in
animal models of pneumonia (Yu et al., 2001). NADH oxidase is
encoded by nox. The virulence and persistence in mice of a blood
isolate was attenuated by a nox insertion mutation (Auzat et al.,
1999). Thus, this protein appears to be of major importance in
the growth of biofilms.
CONCLUSIONS
Our study suggested that sub-MICs of tylosin could inhibit S.
suis biofilm formation in vitro. We used a robust and reliable
comparative proteomic technique (iTRAQ) to compare the
abundances of proteins from 1/4 MIC of tylosin treated cells
and nontreated cells. Finally, in sub-MIC tylosin inhibiting
cells, we identified 96 differentially expressed proteins when
the protein had a fold-change of more than a ratio >1.5 or
<0.67 (p < 0.05). Our proteomic data suggested general changes
in metabolism (such as phosphoglycerate kinase) and surface
proteins (such as ABC transporter proteins) involved in biofilm
formation. Overall, our results indicated that S. suis metabolic
regulation, cell-surface proteins, and virulence proteins appear
to be of importance in biofilm growth by sub-MIC tylosin
treatment. Thus, our data revealed the rough regulation of
biofilm formation that might potentially be utilized to manage
biofilm infections of S. suis.
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